Defunct Company
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
2,221
NCT02521649
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
Phase: Phase 2
Role: Collaborator
Start: Sep 30, 1998
Completion: Jan 31, 2001
NCT02749396
EPID Multiple Sclerosis Pregnancy Study
Phase: N/A
Start: May 2, 2016
Completion: Aug 14, 2018
NCT07165197
Visual Performance of Clareon Vivity and PureSee IOL
Role: Lead Sponsor
Start: Jun 27, 2025
Completion: Mar 31, 2026